Search

Mansour Oveissi

Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )

Most Active Art Unit
2415
Art Unit(s)
2616, 2464, 2415, 2416
Total Applications
1005
Issued Applications
795
Pending Applications
89
Abandoned Applications
156

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18483472 [patent_doc_number] => 20230210767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/998895 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998895
PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME May 17, 2021 Pending
Array ( [id] => 18483472 [patent_doc_number] => 20230210767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/998895 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998895
PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME May 17, 2021 Pending
Array ( [id] => 17420061 [patent_doc_number] => 11253490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-02-22 [patent_title] => Compositions and methods of treating cognitive impairment [patent_app_type] => utility [patent_app_number] => 17/322316 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2063 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322316 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322316
Compositions and methods of treating cognitive impairment May 16, 2021 Issued
Array ( [id] => 17936418 [patent_doc_number] => 11470847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Antimicrobial glass compositions, glasses and polymeric articles incorporating the same [patent_app_type] => utility [patent_app_number] => 17/321905 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 20351 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17321905 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/321905
Antimicrobial glass compositions, glasses and polymeric articles incorporating the same May 16, 2021 Issued
Array ( [id] => 18420095 [patent_doc_number] => 20230174556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => COMPOUNDS AS PROTEIN KINASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/998998 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25975 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998998 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998998
COMPOUNDS AS PROTEIN KINASE INHIBITORS May 13, 2021 Pending
Array ( [id] => 17921011 [patent_doc_number] => 11464232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Antimicrobial glass compositions, glasses and polymeric articles incorporating the same [patent_app_type] => utility [patent_app_number] => 17/316020 [patent_app_country] => US [patent_app_date] => 2021-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 20290 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/316020
Antimicrobial glass compositions, glasses and polymeric articles incorporating the same May 9, 2021 Issued
Array ( [id] => 17124387 [patent_doc_number] => 20210299155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => METHODS OF MODULATING IMMUNE ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/313296 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/313296
Methods of modulating immune activity May 5, 2021 Issued
Array ( [id] => 17124381 [patent_doc_number] => 20210299149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION [patent_app_type] => utility [patent_app_number] => 17/307275 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307275 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307275
Methods and compositions for treating meibomian gland dysfunction May 3, 2021 Issued
Array ( [id] => 17065760 [patent_doc_number] => 20210267975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/238869 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238869 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/238869
Amorphous nilotinib microparticles and uses thereof Apr 22, 2021 Issued
Array ( [id] => 17007218 [patent_doc_number] => 20210238379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => Dendritic Macroporous Hydrogels Prepared By Crystal Templating [patent_app_type] => utility [patent_app_number] => 17/231653 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6385 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231653
Dendritic macroporous hydrogels prepared by crystal templating Apr 14, 2021 Issued
Array ( [id] => 17124353 [patent_doc_number] => 20210299121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => CETIRIZINE OPHTHALMIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/217760 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17217760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/217760
CETIRIZINE OPHTHALMIC COMPOSITIONS Mar 29, 2021 Abandoned
Array ( [id] => 18449409 [patent_doc_number] => 20230190685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => FORMULATION [patent_app_type] => utility [patent_app_number] => 17/995053 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56400 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995053 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995053
FORMULATION Mar 25, 2021 Abandoned
Array ( [id] => 17140143 [patent_doc_number] => 20210308154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => Methods and Compositions for Treating Meibomian Gland Dysfunction [patent_app_type] => utility [patent_app_number] => 17/210648 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210648
Methods and Compositions for Treating Meibomian Gland Dysfunction Mar 23, 2021 Abandoned
Array ( [id] => 18558693 [patent_doc_number] => 11723918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Solid pharmaceutical tablet [patent_app_type] => utility [patent_app_number] => 17/206226 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206226 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206226
Solid pharmaceutical tablet Mar 18, 2021 Issued
Array ( [id] => 17168675 [patent_doc_number] => 20210322345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/202238 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202238
MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF Mar 14, 2021 Abandoned
Array ( [id] => 17306333 [patent_doc_number] => 11207416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Compositions and methods for targeted RNA delivery [patent_app_type] => utility [patent_app_number] => 17/192709 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 100796 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192709 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/192709
Compositions and methods for targeted RNA delivery Mar 3, 2021 Issued
Array ( [id] => 16898955 [patent_doc_number] => 20210177871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHODS FOR CANCER THERAPY [patent_app_type] => utility [patent_app_number] => 17/188492 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188492 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188492
Methods for cancer therapy Feb 28, 2021 Issued
Array ( [id] => 17290799 [patent_doc_number] => 20210386638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => SHAVE-CLEANSER COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/182919 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6968 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182919 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182919
Shave-cleanser composition Feb 22, 2021 Issued
Array ( [id] => 17755540 [patent_doc_number] => 11395818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea [patent_app_type] => utility [patent_app_number] => 17/180241 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25974 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180241 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180241
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea Feb 18, 2021 Issued
Array ( [id] => 18618542 [patent_doc_number] => 11751563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Pathogen eliminating article and methods of manufacturing and using the same [patent_app_type] => utility [patent_app_number] => 17/175893 [patent_app_country] => US [patent_app_date] => 2021-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 8134 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/175893
Pathogen eliminating article and methods of manufacturing and using the same Feb 14, 2021 Issued
Menu